ABHD12 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86941
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of ABHD12. Peptide sequence: APSRSFRDFKVQFIPFHSDLGYRHKYIYKSPELPRILREFLGKSEPERQH The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for ABHD12 Antibody - BSA Free
![Western Blot: ABHD12 Antibody [NBP2-86941]](https://resources.bio-techne.com/images/products/ABHD12-Antibody-Western-Blot-NBP2-86941-img0001.jpg "Western Blot: ABHD12 Antibody [NBP2-86941]")
Western Blot: ABHD12 Antibody [NBP2-86941]
Western Blot: ABHD12 Antibody [NBP2-86941] - WB Suggested Anti-Abhd12 Antibody. Titration: 1.0 ug/ml. Positive Control: Mouse ThymusApplications for ABHD12 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ABHD12
Alternate Names
ABHD12A, abhydrolase domain containing 12, Abhydrolase domain-containing protein 12, BEM46L2, C20orf22, chromosome 20 open reading frame 22, dJ965G21.2, DKFZP434P106, DKFZp434P106,2-arachidonoylglycerol hydrolase, EC 3.1.1.23, monoacylglycerol lipase ABHD12, PHARC
Gene Symbol
ABHD12
Additional ABHD12 Products
Product Specific Notices for ABHD12 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...